Craig Morgan


The Emergence of the Few: M&A in the CRO Industry

October 30, 2017

As the size, complexity, duration, cost, and globalization of clinical trials has grown, pharmaceutical and biotech companies have moved to outsource clinical activities to CROs to achieve a wide range of objectives.

Eliminating the Three Evil "E's" in Starting Clinical Trials

September 16, 2016

Pharma has been transitioning from its paper based methods of the past toward automated cloud based systems in order to offset the cost of drug development. The emphasis is now shifting toward improved study startup processes for shorter clinical trial timelines.